Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit

Francis Bessière; Hugo Roccia; Antoine Delinière; Rome Charrière; Philippe Chévalier; Laurent Argaud; Martin Cour

doi:10.1001/jamacardio.2020.1787

Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit

Francis Bessière(Hospices Civils de Lyon), Hugo Roccia(Hospices Civils de Lyon), Antoine Delinière(Hospices Civils de Lyon), Rome Charrière(Centre Hospitalier de Valence), Philippe Chévalier(Hospices Civils de Lyon), Laurent Argaud(Hôpital Edouard Herriot), Martin Cour(Hôpital Louis Pradel)

JAMA Cardiology

May 1, 2020

10.1001/jamacardio.2020.1787

Cited by 281Open Access

Full Text

Abstract

average of 1 hour per patient to ensure they can afford tafamidis. As such, our experience might not be easily applicable to other health care settings.

Related Papers

No related papers found

Powered by citation graph analysis